Publication | Closed Access
Phase II trial of circadian infusion floxuridine (FUDR) in hormone refractory metastatic prostate cancer
10
Citations
16
References
1998
Year
UrologyOncologyPhase Ii TrialMedicinePharmacotherapyProstatic DiseasePharmacologyCircadian Infusion Floxuridine
| Year | Citations | |
|---|---|---|
Page 1
Page 1